FDA Investigator Yetao Jin, PhD
Yetao Jin, PhD has conducted inspections on 4 sites in 4 countries as of 02 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
02 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Malaysia,
Korea (Republic of),
Iceland,
United States of America
FDA Investigators that have inspected at least one site in common with Yetao Jin, PhD:
Amy C Jordan,
Amy N Chen,
Anjali Shukla, PhD,
Arsen Karapetyan,
Bingchen Du, PhD,
Calvin B Koerner,
Cynthia Jim, CSO,
Daniel J Lahar,
Daryl A Dewoskin,
Dien N Nguyen,
Donald C Obenhuber, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Eileen A Liu,
Hamet M Toure, PharmD MPH,
Jacek Cieslak, PhD,
José E Meléndez,
Julie D Bringger,
Karen A Briggs,
Katherine D Adams,
Lei Zhang, PhD,
Leiyun Boone, PhD,
Linda F Murphy,
Madushini Dharmasena, PhD,
Maria Joselopez Barragan, PhD,
Mark R Mcclain,
Maryam Tabatabaie,
Megan A Haggerty,
Mekonnen Lemma Dechassa, PhD,
Michael Shanks, MS,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Nealie C Newberger,
Patty P Kaewussdangkul,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Robert D Tollefsen,
Roger F Zabinski,
Rong Guo,
Santos E Camara,
Scott C Lute,
Sean R Marcsisin,
Shawn E Larson,
Stacey S Degarmo,
Steven Fong, MS, PhD,
Vidya B Pai,
Wayne E Seifert,
William Hallett, PhD,
Zhong Li, PhD,
Ziyang Su, PhD
Yetao Jin, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2019 | FDA 483 | Immunex Rhode Island Corporation - Form 483, 2019-04-19 |
March, 2022 | FDA 483 | Alvotech Hf - Form 483, 2022-03-22 |
March, 2023 | FDA 483 | Hugel, Inc. - Form 483, 2023-03-10 |
September, 2021 | FDA 483 | BIOCON SDN.BHD. - Form 483, 2021-09-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more